Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - valganciclovir hydrochloride, quantity: 496.3 mg (equivalent: valganciclovir, qty 450 mg) - tablet, film coated - excipient ingredients: povidone; stearic acid; crospovidone; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 6000; iron oxide red - valgan is indicated for the treatment of cytomegalovirus (cmv) retinitis in adult patients with acquired immunodeficiency syndrome (aids)., valgan is indicated for the prophylaxis of cmv disease in adult and paediatric solid organ transplantation (sot) patients who are at risk.

Singapore - English - HSA (Health Sciences Authority)

sandoz singapore pte. ltd. - valganciclovir hydrochloride eqv valganciclovir - tablet, film coated - valganciclovir hydrochloride eqv valganciclovir 450mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - valganciclovir hydrochloride - oral solution - 114mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - valganciclovir hydrochloride - oral suspension - 114mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - valganciclovir hydrochloride - oral tablet - 450mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cipla eu ltd - valganciclovir hydrochloride - oral tablet - 450mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

amarox ltd - valganciclovir hydrochloride - oral tablet - 450mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glenmark pharmaceuticals europe ltd - valganciclovir hydrochloride - oral tablet - 450mg

Ireland - English - HPRA (Health Products Regulatory Authority)

roche products limited - valganciclovir hydrochloride - powder for oral solution - 50 mg/ml - nucleosides and nucleotides excl. reverse transcriptase inhibitors

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

neon healthcare ltd - valganciclovir hydrochloride - oral solution - 50mg/1ml